CD5E:SW:SW-Amundi Index Solutions - Amundi EURO STOXX 50 UCITS ETF-D EUR EUR (EUR)

ETF | Others |

Last Closing

USD 84.62

Change

0.00 (0.00)%

Market Cap

N/A

Volume

621.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.11 (-0.79%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

-0.10 (-0.59%)

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.16 (-0.75%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-0.11 (-0.37%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+17.00 (+0.26%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-7.50 (-0.36%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-11.00 (-0.41%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-0.55 (-0.70%)

USD 131,872.43B

ETFs Containing CD5E:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.30% 89% A- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.30% 89% A- 85% B
Trailing 12 Months  
Capital Gain 5.43% 61% D- 61% D-
Dividend Return 2.72% 61% D- 57% F
Total Return 8.15% 70% C- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.87% 67% D+ 68% D+
Dividend Return 8.35% 69% C- 70% C-
Total Return 0.49% 68% D+ 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 7.70% 57% F 62% D
Risk Adjusted Return 108.47% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike